tyrphostin a23 has been researched along with Carcinoma, Epidermoid in 2 studies
tyrphostin A23: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gazit, A | 1 |
| Yaish, P | 1 |
| Gilon, C | 1 |
| Levitzki, A | 1 |
| Faaland, CA | 1 |
| Mermelstein, FH | 1 |
| Hayashi, J | 1 |
| Laskin, JD | 1 |
2 other studies available for tyrphostin a23 and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.
Topics: Benzylidene Compounds; Carcinoma, Squamous Cell; Cell Division; Cell Line; Epidermal Growth Factor; | 1989 |
Rapid uptake of tyrphostin into A431 human epidermoid cells is followed by delayed inhibition of epidermal growth factor (EGF)-stimulated EGF receptor tyrosine kinase activity.
Topics: Biological Transport; Carcinoma, Squamous Cell; Catechols; Cell Division; Cell Line; Enzyme Activati | 1991 |